Avanos Medical AVNS Neonate solutions — Net Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's neonate solutions — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avanos Medical's neonate solutions — net sales?
- Avanos Medical (AVNS) reported neonate solutions — net sales of $39.4M in Q1 2026.
- How has Avanos Medical's neonate solutions — net sales changed year-over-year?
- Avanos Medical's neonate solutions — net sales increased by 48.1% year-over-year, from $26.6M to $39.4M.
- What is the long-term trend for Avanos Medical's neonate solutions — net sales?
- Over 2 years (2023 to 2025), Avanos Medical's neonate solutions — net sales has grown at a 15.7% compound annual growth rate (CAGR), from $88.3M to $118.2M.
- What does neonate solutions — net sales mean?
- This metric represents the total revenue generated from the sale of medical devices and solutions specifically designed for neonatal care. It reflects the company's market penetration and commercial success within the specialized pediatric and infant healthcare segment. Growth in this area indicates successful adoption of neonatal product offerings and the company's ability to address critical clinical needs in early-life medical interventions.